News

OBIO Announces Expansion of Early Adopter Health Network Partnerships

September 29, 2021

Logo EAHN

October marks third EAHN™ cohort selection to commercialize innovative technologies

TORONTO, ON – September 29, 2021 – The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is proud to announce the growth and expansion of its Early Adopter Health Network (EAHN™) partnerships, together with the upcoming selection round of its new cohort.

With more than 18 healthcare members and 11 innovation organization partners from across Canada, the EAHN™ has grown into Canada’s premier health science market acceleration program since its launch in early 2020. Now, OBIO® will be hosting its third cohort network day in October, where innovative companies will meet with healthcare organizations prior to launching new EAHN™ projects later this year.

“We are delighted to expand the EAHN™ with the engagement of so many leading healthcare organizations and with the support of our innovation organization partners,” said Gail Garland, President & CEO of OBIO®. “Growing and maintaining a robust and globally competitive domestic health science industry ecosystem here in Canada requires partnerships and collaborations to get the job done.”

Through the EAHN™, which is supported by the Federal Economic Development Agency of Southern Ontario, OBIO® provides project management and financial support to evaluate technologies in the real-world setting and facilitate their broad adoption into the health system. They connect leading-edge, scaling health science companies with healthcare organizations, providing an opportunity for innovators to access local markets before expanding globally, as well as a strong reason to anchor themselves in Canada.

Driven by OBIO’s unique capacity to pair commercial-ready technologies with clinical end-users who want to deliver improved care at any health institution, the goal for the EAHN™ is to become early adopters of homegrown medical technology and help streamline the procurement process. Through a collaborative and comprehensive approach, EAHN™ addresses both the “push” and “pull” factors of what industry has developed and what burdened hospitals are trying to address. This allows the EAHN™ to catalyze change by delivering improved patient care more efficiently while opening the door to a new health-care economy that benefits Canadians and Canadian companies alike.

OBIO® would like to thank and recognize the following organizations for their involvement and support in the EAHN™:

EAHN™ Healthcare Members:

  • Baycrest
  • Bruyère
  • Centre for Addiction and Mental Health (CAMH)
  • Hamilton Health Sciences
  • Health Sciences North
  • Hôtel-Dieu Grace Healthcare
  • Joseph Brant Hospital
  • Kingston Health Sciences Centre
  • Michael Garron Hospital
  • North York General Hospital
  • Southlake Regional Health Centre
  • St. Mary’s General Hospital
  • The Ottawa Hospital
  • Unity Health Toronto
  • University Health Network (UHN)
  • West Park Healthcare Centre
  • Winchester District Memorial Hospital
  • Women’s College Hospital

EAHN™ Innovation Organization Partners:

  • Carleton University
  • Clinical Trials Ontario
  • Invest Ottawa
  • Life Sciences British Columbia
  • Montréal InVivo
  • Ontario Institute for Regenerative Medicine
  • Ryerson Biomedical Zone
  • SOSCIP Consortium
  • StarFish Medical
  • Stem Cell Network
  • Synapse Life Science Consortium

For more information about OBIO’s EAHN™, or if you are interested in being part of the network, please contact Dr. Jeff Aramini at jeffaramini@obio.ca.

About OBIO®

OBIO®, founded in 2009, is a not-for-profit, membership-based innovation organization engaged in strategy, programming, policy development and advocacy to further the commercialization of human health technologies positioning Canada as a leader in the international marketplace. OBIO® advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.

For media inquiries, please contact:

Bojana Duric, BlueSky Communications
bduric@blueskycommunications.com
289.981.7710

For any additional questions, please contact us.